Placental transport dysfunction in omega-3 and omega-6 fatty acid in patients with gestational diabetes mellitus.
GDM affects fatty acid transport from mother to fetus, with significant changes in specific fatty acid ratios that could impact fetal development.
Where it sits
this study against the rest of the dihexa corpusSummary and findings
This study investigated fatty acid transport from mother to fetus in gestational diabetes mellitus (GDM) compared to healthy pregnancies. The analysis involved 20 healthy and 20 GDM pregnancies, focusing on fatty acid profiles. Significant alterations in fatty acid ratios were observed in GDM pregnancies.
Abstract
<h4>Background</h4>Gestational diabetes mellitus (GDM) affects the transfer of fatty acid (FA) from mother to fetus. However, the specific transport alterations remain unclear. This study investigated FA transport from mother to fetus in GDM.<h4>Methods</h4>Maternal serum, umbilical cord serum, and placental tissues were collected from 20 healthy (normal group) and 20 GDM pregnancies receiving glycemic management (GDM group). Fifty-one FA were quantified by gas chromatography-mass spectrometry. Placenta/mother and fetus/placenta ratios of FA compositions were compared between groups using Student's t-test or Mann-Whitney U test, as appropriate.<h4>Results</h4>The concentrations and compositions of FA profiles were both changed in GDM. The placenta/mother ratios of cis-11,14,17-eicosatrienoic acid (GDM vs normal: 0.648 vs 0.484, <i>p</i> = 0.001), cis-5,8,11,14,17-eicosapentaenoic acid (0.449 vs 0.338, <i>p</i> = 0.048), cis-13,16-docosadienoic acid (DDA, 1.436 vs 1.187, <i>p</i> = 0.047), palmitelaidic acid (2.882 vs 2.272, <i>p</i> = 0.023), petroselaidic acid (2.177 vs 1.746, <i>p</i> = 0.004) and linoelaidic acid (1.770 vs 1.423, <i>p</i> = 0.014) were significantly higher in GDM, while the ratio of trans-10-nonadecenoic acid (0.537 vs 0.799, <i>p</i> < 0.001) was lower. The fetus/placenta ratio of total omega-6 long chain polyunsaturated FA (LC PUFA, 0.545 vs 0.590, <i>p</i> = 0.002) with DDA (4.031 vs 4.951, <i>p</i> = 0.031) and cis-7,10,13,16-docosatetraenoic acid (0.494 vs 0.778, <i>p</i> < 0.001) was lower in GDM.<h4>Conclusions</h4>FA profiles in mother, placenta, and fetus were affected by GDM despite glycemic management, especially in omega-3 and omega-6 LC PUFAs. This finding indicates that addressing fetal FA deficiency may depend on correcting placental dysfunction rather than solely increasing maternal FA supplementation, offering insights for developing nutritional and therapeutic strategies for GDM.
Background
This paper addresses the impact of gestational diabetes mellitus (GDM) on fatty acid transport from mother to fetus, a critical aspect given the importance of fatty acids for fetal development. Previous research has suggested that GDM alters metabolic processes, but specific transport mechanisms for fatty acids remain poorly understood. Understanding these alterations is essential for developing nutritional strategies to support fetal health in GDM.
Methods
The study utilized a comparative design involving 20 healthy pregnancies and 20 GDM pregnancies receiving glycemic management. Maternal serum, umbilical cord serum, and placental tissues were collected for analysis. Fatty acids were quantified using gas chromatography-mass spectrometry, and comparisons of fatty acid ratios between groups were made using Student's t-test or Mann-Whitney U test.
Results
The placenta/mother ratio of cis-11,14,17-eicosatrienoic acid was 0.648 in GDM compared to 0.484 in normal pregnancies, with a p-value of 0.001. Other significant findings included a higher placenta/mother ratio of palmitelaidic acid (2.882 vs 2.272, p=0.023) and a lower fetus/placenta ratio of total omega-6 long chain polyunsaturated FA (0.545 vs 0.590, p=0.002).
Interpretation
The findings indicate that GDM significantly alters fatty acid transport ratios, which may have implications for fetal development. While some results are statistically significant, the clinical relevance of these changes requires further investigation, particularly given the small sample size and potential confounding factors. This study adds to the understanding of metabolic alterations in GDM but should be interpreted with caution.
Key findings
- placenta/mother ratio of cis-11,14,17-eicosatrienoic acid (GDM vs normal: 0.648 vs 0.484, p=0.001)
- placenta/mother ratio of cis-5,8,11,14,17-eicosapentaenoic acid (0.449 vs 0.338, p=0.048)
- placenta/mother ratio of cis-13,16-docosadienoic acid (1.436 vs 1.187, p=0.047)
- placenta/mother ratio of palmitelaidic acid (2.882 vs 2.272, p=0.023)
- placenta/mother ratio of petroselaidic acid (2.177 vs 1.746, p=0.004)
- fetus/placenta ratio of total omega-6 long chain polyunsaturated FA (0.545 vs 0.590, p=0.002)
Limitations
- small sample size of 20 participants per group
- results may not be generalizable
- only focused on fatty acid transport without broader metabolic context
- cross-sectional design limits causal inferences